Latest Surefire Medical Inc. Stories
Study presented at SIR: Surefire results in statistically significant tumor uptake ATLANTA, March 3, 2015 /PRNewswire/ --
Growing body of clinical evidence shows greater penetration, targeted delivery, efficiency and cost savings with the SIS WESTMINSTER, Colo., Dec.
WESTMINSTER, Colo., Nov.
WESTMINSTER, Colo., Oct.
Preliminary Observations Presented at GEST Show Increased Tumor Penetration with the Surefire SAN FRANCISCO, May 1, 2014 /PRNewswire/ --
Results: Fluoroscopy time reduced by 70%; Procedure Time, Contrast Dose Cut 50% WESTMINSTER, Colo., April 23, 2014 /PRNewswire/ --
Study presented at SIR also concludes coiling can be eliminated or minimized with use of the technologically advanced Surefire Infusion System SAN DIEGO, March 26, 2014 /PRNewswire/
WESTMINSTER, Colo., March 13, 2014 /PRNewswire/ -- Surefire Medical, Inc., developer of a new class of infusion systems
- Growing in low tufty patches.